Kaempferol suppresses lipid accumulation in macrophages through the downregulation of cluster of differentiation 36 and the upregulation of scavenger receptor class B type i and ATP-binding cassette transporters A1 and G1

International Journal of Molecular Medicine

Volumn 31, Issue 2, 2013, Pages 331-338

  Li, Xiu Ying ^a   Kong, Ling Xi ^a   Li, Juan ^a   He, Hai Xia ^a   Zhou, Yuan Da ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Activator protein 1; ATP binding cassette transporter A1; ATP binding cassette transporter G1; Cluster of differentiation 36; Heme oxygenase 1; Kaempferol; Scavenger receptor class B type I

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CD36 ANTIGEN; CHOLESTEROL; HEME OXYGENASE 1; KAEMPFEROL; MESSENGER RNA; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR BI; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE 1;

ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FOAM CELL; GENE SILENCING; HUMAN; HUMAN CELL; LIPID STORAGE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD36; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CELL SURVIVAL; CHOLESTEROL; DOWN-REGULATION; HEME OXYGENASE-1; HUMANS; KAEMPFEROLS; LIPID METABOLISM; LIPOPROTEINS, LDL; MACROPHAGES; PROTO-ONCOGENE PROTEINS C-JUN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 84873109054     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1204     Document Type: Article

References (34)

1. Tsimikas S, Miyanohara A, Hartvigsen K, et al: Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol 58: 1715-1727, 2011.
2. Sung HJ, Kim J, Kim Y, Jang SW and Ko J: N-acetyl cysteine suppresses the foam cell formation that is induced by oxidized low density lipoprotein via regulation of gene expression. Mol Biol Rep 39: 3001-3007, 2012.
3. Li AC and Glass CK: The macrophage foam cell as a target for therapeutic intervention. Nat Med 8: 1235-1242, 2002.
4. Kleemann R, Zadelaar S and Kooistra T: Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79: 360-376, 2008.
5. Hrboticky N, Draude G, Hapfelmeier G, Lorenz R and Weber PC: Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages. Arterioscler Thromb Vasc Biol 19: 1267-1275, 1999.
6. Wang X and Rader DJ: Molecular regulation of macrophage reverse cholesterol transport. Curr Opin Cardiol 22: 368-372, 2007.
7. Cuchel M and Rader DJ: Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 113: 2548-2555, 2006.
8. Chirumbolo S: The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets 9: 263-285, 2010.
9. González-Gallego J, Sánchez-Campos S and Tuñón MJ: Anti-inflammatory properties of dietary flavonoids. Nutr Hosp 22: 287-293, 2007.
10. Calderón-Montaño JM, Burgos-Morón E, Pérez-Guerrero C and López-Lázaro M: A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 11: 298-344, 2011.
11. Park MY, Ji GE and Sung MK: Dietary kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice. Dig Dis Sci 57: 355-363, 2012.
12. Xiao HB, Lu XY, Sun ZL and Zhang HB: Kaempferol regulates OPN-CD44 pathway to inhibit the atherogenesis of apolipoprotein E deficient mice. Toxicol Appl Pharmacol 257: 405-411, 2011.
13. Hong JT, Yen JH, Wang L, Lo YH, Chen ZT and Wu MJ: Regulation of heme oxygenase-1 expression and MAPK pathways in response to kaempferol and rhamnocitrin in PC12 cells. Toxicol Appl Pharmacol 237: 59-68, 2009.
14. Chen CC, Chow MP, Huang WC, Lin YC and Chang YJ: Flavonoids inhibit tumor necrosis factor-alpha-induced upregulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships. Mol Pharmacol 66: 683-693, 2004.
15. Li XY, He JL, Liu HT, Li WM and Yu C: Tetramethylpyrazine suppresses interleukin-8 expression in LPS-stimulated human umbilical vein endothelial cell by blocking ERK, p38 and nuclear factor-kappaB signaling pathways. J Ethnopharmacol 125: 83-89, 2009.
16. Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP and Byrne GI: Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis 180: 780-790, 1999.
17. Cheng LC, Su KH, Kou YR, et al: α-Lipoic acid ameliorates foam cell formation via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1. Free Radic Biol Med 50: 47-54, 2011.
18. Tsai JY, Su KH, Shyue SK, et al: EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovasc Res 88: 415-423, 2010.
19. Lim H and Kim HP: Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids.Planta Med 73: 1267-1274, 2007.
20. Crespo I, García-Mediavilla MV, Gutiérrez B, Sánchez-Campos S, Tuñón MJ and González-Gallego J: A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells. Br J Nutr 100: 968-976, 2008.
21. Abeywardena MY and Head RJ: Dietary polyunsaturated fatty acid and antioxidant modulation of vascular dysfunction in the spontaneously hypertensive rat. Prostaglandins Leukot Essent Fatty Acids 65: 91-97, 2001.
22. Mekhora C, Muangnoi C, Chingsuwanrote P, Dawilai S, Svasti S, Chasri K and Tuntipopipat S: Eryngium foetidum suppresses inflammatory mediators produced by macrophages. Asian Pac J Cancer Prev 13: 653-664, 2012.
23. Tu YC, Lian TW, Yen JH, Chen ZT and Wu MJ: Antiatherogenic effects of kaempferol and rhamnocitrin. J Agric Food Chem 28: 9969-9976, 2007.
24. Witztum JL: You are right too! J Clin Invest 115: 2072-2075, 2005.
25. Kunjathoor VV, Febbraio M, Podrez EA, et al: Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277: 49982-49988, 2002.
26. Katayama I, Hotokezaka Y, Matsuyama T, Sumi T and Nakamura T: Ionizing radiation induces macrophage foam cell formation and aggregation through JNK-dependent activation of CD36 scavenger receptors. Int J Radiat Oncol Biol Phys 70: 835-846, 2008.
27. Oh J, Weng S, Felton SK, et al: 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 120: 687-698, 2009.
28. Duh PD, Hsiao WC and Wang BS: An aqueous extract of Welsh onion green leaves increase ABCA1 and SR-BI expression in macrophage RAW 264.7 cells. Food Chemistry 107: 1029-1038, 2008.
29. Lu KY, Ching LC, Su KH, et al: Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha. Circulation 121: 1828-1837, 2010.
30. Chang YC, Lee TS and Chiang AN: Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J Lipid Res 53: 1840-1850, 2012.
31. Gao J, Xu Y, Yang Y, et al: Identification of upregulators of human ATP-binding cassette transporter A1 via high-throughput screening of a synthetic and natural compound library. J Biomol Screen 13: 648-656, 2008.
32. Ishikawa K, Sugawara D, Wang Xp, Suzuki K, Itabe H, Maruyama Y and Lusis AJ: Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 88: 506-512, 2001.
33. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK and Chau LY: J Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104: 1519-1525, 2001.
34. Idriss NK, Blann AD and Lip GY: Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 52: 971-978, 2008.